CAD, or computer-aided design, has transformed design in many fields, allowing simulation and numerical data modeling in industries such as architecture, engineering, construction, product design and ...

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing ...

A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.

Ottawa, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The global computer-aided drug design (CADD) market is experiencing rapid growth, projected to generate hundreds of millions in revenue between 2025 and 2034.

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages ...